1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Foresite Capital Management IV, LLC Buys Biohaven Pharmaceutical Holding Co, bluebird bio Inc, Kiniksa Pharmaceuticals, Sells The Medicines Co, Aerie Pharmaceuticals Inc, Insmed Inc

Investment company Foresite Capital Management IV, LLC (Current Portfolio) buys Biohaven Pharmaceutical Holding Co, bluebird bio Inc, Kiniksa Pharmaceuticals, uniQure NV, Kura Oncology Inc, sells The Medicines Co, Aerie Pharmaceuticals Inc, Insmed Inc, Arbutus Biopharma Corp, Ascendis Pharma A/S during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Foresite Capital Management IV, LLC. As of 2020Q1, Foresite Capital Management IV, LLC owns 10 stocks with a total value of $69 million. These are the details of the buys and sells.

For the details of Foresite Capital Management IV, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/foresite+capital+management+iv%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Foresite Capital Management IV, LLC
  1. Cytokinetics Inc (CYTK) - 2,177,292 shares, 37.09% of the total portfolio. Shares reduced by 9.24%
  2. MyoKardia Inc (MYOK) - 307,400 shares, 20.82% of the total portfolio. Shares added by 18.06%
  3. Insmed Inc (INSM) - 678,322 shares, 15.71% of the total portfolio. Shares reduced by 52.55%
  4. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 156,355 shares, 7.69% of the total portfolio. New Position
  5. Voyager Therapeutics Inc (VYGR) - 516,751 shares, 6.83% of the total portfolio. Shares reduced by 37.78%
New Purchase: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Foresite Capital Management IV, LLC initiated holding in Biohaven Pharmaceutical Holding Co Ltd. The purchase prices were between $27.51 and $57.29, with an estimated average price of $46.01. The stock is now traded at around $58.80. The impact to a portfolio due to this purchase was 7.69%. The holding were 156,355 shares as of .

New Purchase: bluebird bio Inc (BLUE)

Foresite Capital Management IV, LLC initiated holding in bluebird bio Inc. The purchase prices were between $40.39 and $98.04, with an estimated average price of $75.99. The stock is now traded at around $61.27. The impact to a portfolio due to this purchase was 3.32%. The holding were 50,000 shares as of .

New Purchase: Kiniksa Pharmaceuticals Ltd (KNSA)

Foresite Capital Management IV, LLC initiated holding in Kiniksa Pharmaceuticals Ltd. The purchase prices were between $11 and $19.76, with an estimated average price of $15.6. The stock is now traded at around $20.96. The impact to a portfolio due to this purchase was 1.45%. The holding were 65,000 shares as of .

New Purchase: uniQure NV (QURE)

Foresite Capital Management IV, LLC initiated holding in uniQure NV. The purchase prices were between $40.01 and $73.97, with an estimated average price of $57.92. The stock is now traded at around $63.80. The impact to a portfolio due to this purchase was 1.31%. The holding were 19,082 shares as of .

Added: Kura Oncology Inc (KURA)

Foresite Capital Management IV, LLC added to a holding in Kura Oncology Inc by 36.76%. The purchase prices were between $6.45 and $14.04, with an estimated average price of $11.51. The stock is now traded at around $16.65. The impact to a portfolio due to this purchase was 0.36%. The holding were 93,000 shares as of .

Sold Out: The Medicines Co (MDCO)

Foresite Capital Management IV, LLC sold out a holding in The Medicines Co. The sale prices were between $84.9 and $84.96, with an estimated average price of $84.93.

Sold Out: Arbutus Biopharma Corp (ABUS)

Foresite Capital Management IV, LLC sold out a holding in Arbutus Biopharma Corp. The sale prices were between $1.01 and $3.42, with an estimated average price of $2.72.

Sold Out: Ascendis Pharma A/S (ASND)

Foresite Capital Management IV, LLC sold out a holding in Ascendis Pharma A/S. The sale prices were between $97.01 and $145.11, with an estimated average price of $130.39.

Sold Out: OptiNose Inc (OPTN)

Foresite Capital Management IV, LLC sold out a holding in OptiNose Inc. The sale prices were between $3.49 and $9.22, with an estimated average price of $6.78.

Sold Out: SI-BONE Inc (SIBN)

Foresite Capital Management IV, LLC sold out a holding in SI-BONE Inc. The sale prices were between $8.36 and $22.67, with an estimated average price of $18.5.

Sold Out: Alector Inc (ALEC)

Foresite Capital Management IV, LLC sold out a holding in Alector Inc. The sale prices were between $16.25 and $35.28, with an estimated average price of $25.37.



Here is the complete portfolio of Foresite Capital Management IV, LLC. Also check out:

1. Foresite Capital Management IV, LLC's Undervalued Stocks
2. Foresite Capital Management IV, LLC's Top Growth Companies, and
3. Foresite Capital Management IV, LLC's High Yield stocks
4. Stocks that Foresite Capital Management IV, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)